{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:54:14Z","timestamp":1791453254515,"version":"4.3.3"},"reference-count":81,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI127406"],"award-info":[{"award-number":["AI127406"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hyper-immunoglobulin E syndrome (HIES) is a primary immunodeficiency disease characterized by recurrent Staphylococcus aureus (S. aureus) infections, eczema, skeletal abnormalities and high titers of serum immunoglobulin E. Although the genetic basis of HIES was not known for almost a half century, HIES most frequently exhibits autosomal dominant trait that is transmitted with variable expressivity. Careful genetic studies in recent years identified dominant-negative mutations in human signal transducer and activator of transcription 3 (STAT3) gene as the cause of sporadic and dominant forms of HIES. The STAT3 mutations were localized to DNA-binding, SRC homology 2 (SH2) and transactivating domains and disrupted T helper 17 (TH17) cell differentiation and downstream expression of TH17 cytokines IL-17 and IL-22. Deficiency of IL-17 and IL-22 in turn is responsible for suboptimal expression of anti-staphylococcal host factors, such as neutrophil-recruiting chemokines and antimicrobial peptides, by human keratinocytes and bronchial epithelial cells. TH17 cytokines deficiency thereby explains the recurrent staphylococcal lung and skin infections of HIES patients.<\/jats:p>","DOI":"10.3390\/ijms21239152","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T13:08:51Z","timestamp":1606828131000},"page":"9152","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Staphylococcus aureus and Hyper-IgE Syndrome"],"prefix":"10.3390","volume":"21","author":[{"given":"Bonggoo","family":"Park","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases and the Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nrmicro1289","article-title":"Immune evasion by staphylococci","volume":"3","author":"Foster","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"Wertheim","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71R","DOI":"10.1203\/PDR.0b013e31819dc44d","article-title":"Molecular Pathogenesis of Staphylococcus aureus Infection","volume":"65","author":"Liu","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1086\/533591","article-title":"Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection","volume":"46","author":"Gordon","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni1235","article-title":"Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases","volume":"6","author":"Rooijakkers","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00109-009-0573-x","article-title":"Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence","volume":"88","author":"Graves","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tim.2005.10.002","article-title":"Staphylococcal innate immune evasion","volume":"13","author":"Rooijakkers","year":"2005","journal-title":"Trends Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureusin Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department","volume":"355","author":"Moran","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(08)70002-5","article-title":"Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus","volume":"31","author":"Gould","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/femsre\/fuz030","article-title":"Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms","volume":"44","author":"Miller","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","article-title":"Extreme hyperimmunoglobulinemia E and undue susceptibility to infection","volume":"49","author":"Buckley","year":"1972","journal-title":"Pediatrics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"JOB\u2019S SYNDROME","volume":"287","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE Syndrome with Recurrent Infections\u2014An Autosomal Dominant Multisystem Disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00125817-199907000-00008","article-title":"Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation","volume":"1","author":"Grimbacher","year":"1999","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/302547","article-title":"Genetic Linkage of Hyper-IgE Syndrome to Chromosome 4","volume":"65","author":"Grimbacher","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 Mutations in the Hyper-IgE Syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2011.06387.x","article-title":"Hyper-IgE syndrome update","volume":"1250","author":"Sowerwine","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","article-title":"Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome","volume":"122","author":"Renner","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20080321","article-title":"Mutations in STAT3 and IL12RB1 impair the development of human IL-17\u2013producing T cells","volume":"205","author":"Puel","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","article-title":"Paucity of genotype\u2013phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)","volume":"139","author":"Heimall","year":"2011","journal-title":"Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coi.2014.01.015","article-title":"STAT3 is a central regulator of lymphocyte differentiation and function","volume":"28","author":"Kane","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e20191804","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Tavernier","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20111229","article-title":"Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome","volume":"210","author":"Kotlarz","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0889-8588(18)30632-4","article-title":"Clinical and Immunologic Aspects of the Hyperimmunoglobulin E Syndrome","volume":"2","author":"Leung","year":"1988","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1034\/j.1399-3038.2000.00091.x","article-title":"Hyperimmunoglobulin-E syndrome with recurrent infection: A review of current opinion and treatment","volume":"11","year":"2000","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2249.2005.02805.x","article-title":"Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome","volume":"140","author":"Tanaka","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0091-6749(91)90126-9","article-title":"Antibody responses to protein, polysaccharide, and \u03a6X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome","volume":"87","author":"Sheerin","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.4049\/jimmunol.125.6.2437","article-title":"IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections","volume":"125","author":"Berger","year":"1980","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI111683","article-title":"Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job\u2019s) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A","volume":"75","author":"Dreskin","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.4049\/jimmunol.172.9.5154","article-title":"Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells","volume":"172","author":"Gauchat","year":"2004","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20091706","article-title":"B cell\u2013intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans","volume":"207","author":"Avery","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1182\/blood-2002-04-1115","article-title":"Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C\u03b5 transcription of IL-4\u2013stimulated B cells","volume":"100","author":"Suto","year":"2002","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cellimm.2005.01.001","article-title":"IL-21 effects on human IgE production in response to IL-4 or IL-13","volume":"231","author":"Wood","year":"2004","journal-title":"Cell. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/all.13969","article-title":"Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome","volume":"74","author":"McKenzie","year":"2019","journal-title":"Allergy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/cix140","article-title":"Reduced Immunoglobulin (Ig) G Response to Staphylococcus aureus in STAT3 Hyper-IgE Syndrome","volume":"64","author":"Stentzel","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.humimm.2005.04.009","article-title":"Hyper-IgE Syndrome Is Not Associated with Defects in Several Candidate Toll-Like Receptor Pathway Genes","volume":"66","author":"Hawn","year":"2005","journal-title":"Hum. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10875-005-4183-2","article-title":"No Indication for a Defect in Toll-Like Receptor Signaling in Patients with Hyper-IgE Syndrome","volume":"25","author":"Renner","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20120260","article-title":"Innate Stat3-mediated induction of the antimicrobial protein Reg3\u03b3 is required for host defense against MRSA pneumonia","volume":"210","author":"Choi","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.20082767","article-title":"Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome","volume":"206","author":"Minegishi","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nri3010","article-title":"Immunity against Staphylococcus aureus cutaneous infections","volume":"11","author":"Miller","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/eji.201847650","article-title":"Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome","volume":"48","author":"Farmand","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1172\/JCI121486","article-title":"TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome","volume":"128","author":"Myles","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: An updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.smim.2007.10.015","article-title":"Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation","volume":"19","author":"Chen","year":"2007","journal-title":"Semin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 Family Members and Inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex","volume":"177","author":"Toy","year":"2006","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/422329","article-title":"Requirement of Interleukin-17A for Systemic Anti\u2013Candida albicansHost Defense in Mice","volume":"190","author":"Huang","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20100799","article-title":"Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells","volume":"208","author":"Saito","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/intimm\/dxn134","article-title":"Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: Lessons from a primary immunodeficiency","volume":"21","author":"Minegishi","year":"2008","journal-title":"Int. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11882-008-0075-x","article-title":"Genetic origins of hyper-IgE syndrome","volume":"8","author":"Minegishi","year":"2008","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","article-title":"Hyper-IgE syndromes","volume":"203","author":"Grimbacher","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ACI.0b013e3282f1baea","article-title":"Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency","volume":"7","author":"Minegishi","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20050193","article-title":"Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae","volume":"202","author":"Happel","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic Granulomatous Disease: Report on a National Registry of 368 Patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nri2433","article-title":"Cytokine-mediated regulation of antimicrobial proteins","volume":"8","author":"Kolls","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.170.9.4432","article-title":"Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection","volume":"170","author":"Happel","year":"2003","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","article-title":"Distinct regulation of interleukin-17 in human T helper lymphocytes","volume":"56","author":"Chen","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","article-title":"IL-17 Markedly Up-Regulates \u03b2-Defensin-2 Expression in Human Airway Epithelium via JAK and NF-\u03baB Signaling Pathways","volume":"173","author":"Kao","year":"2004","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.M210429200","article-title":"Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine\/Autocrine Loop","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/rcmb.2002-0255PS","article-title":"Interleukin-17","volume":"28","author":"Kolls","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 Increases the Innate Immunity of Tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri3228","article-title":"Epithelial antimicrobial defence of the skin and intestine","volume":"12","author":"Gallo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.alit.2017.08.004","article-title":"Role of the microbiota in skin immunity and atopic dermatitis","volume":"66","author":"Yamazaki","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2005.11.004","article-title":"Cationic host defense (antimicrobial) peptides","volume":"18","author":"Brown","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Paterson, M.J., Caldera, J.R., Liu, G.Y., Underhill, D.M., Nguyen, C., Sharma, P., Castro, A.M., Kolar, S.L., Tsai, C.-M., and Limon, J.J. (2020). Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy. PLOS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008733"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.chom.2017.08.008","article-title":"O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection","volume":"22","author":"Sanchez","year":"2017","journal-title":"Cell Host Microbe"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/9152\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:40:01Z","timestamp":1760179201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/9152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":81,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21239152"],"URL":"https:\/\/doi.org\/10.3390\/ijms21239152","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}